Stephan Ludwig

Augenstern — Germany

Medicine · Health Sciences

78h-index20.7kcitations518works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(144), interferon and immune responses(137), Immune Response and Inflammation(70), SARS-CoV-2 and COVID-19 Research(42), Respiratory viral infections research(33)

Publications517 total

Inhibitors of cellular RSK isoforms exhibit anti-SARS-CoV-2 activity, enhance efficacy of direct-acting antivirals, and suppress emergence of resistance
Drug Resistance Updates·2026Open Access
Challenges of broad-spectrum antiviral drug discovery and development for emerging pathogens
Drug Discovery Today·2025
Antiviral and immunomodulatory effect of zapnometinib in animal models and hospitalized COVID-19 patients
Frontiers in Immunology·2025· 2 citedOpen Access
Controlling the Sulfation Density of Glycosaminoglycan Glycopolymer Mimetics Enables High Antiviral Activity against SARS-CoV-2 and Reduces Anticoagulant Activity
Biomacromolecules·2025· 5 citedOpen Access
SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients
Vaccines·2025Open Access
Influenza A virus NS1 suppresses nuclear speckles promoted gene expression by inhibition of transcription
npj Viruses·2025· 5 citedOpen Access
Antiviral activity against HSV-1 of triterpene saponins from Anagallis arvensis is related tothe fusion-inhibitory activity of desglucoanagalloside B
Fitoterapia·2025· 1 citedOpen Access
Metabolic interference impairs influenza A virus replication by dampening vRNA synthesis
npj Viruses·2025· 2 citedOpen Access
Influenza H5Nx viruses are susceptible to MEK1/2 inhibition by zapnometinib
Emerging Microbes & Infections·2025· 5 citedOpen Access
Host-targeted antivirals against SARS-CoV-2 in clinical development - Prospect or disappointment?
Antiviral Research·2025· 8 citedOpen Access
Characterisation of the antibody-mediated selective pressure driving intra-host evolution of SARS-CoV-2 in prolonged infection
PLoS Pathogens·2024· 13 citedOpen Access
Molecular characterisation of influenza B virus from the 2017/18 season in primary models of the human lung reveals improved adaptation to the lower respiratory tract
Emerging Microbes & Infections·2024· 2 citedOpen Access
The anti-inflammatory and tolerogenic potential of small spleen peptides
Frontiers in Immunology·2024· 1 citedOpen Access
Cannabigerol and Cannabicyclol Block SARS-CoV-2 Cell Fusion
Planta Medica·2024· 10 cited
Conversion of dendritic cells into tolerogenic or inflammatory cells depends on the activation threshold and kinetics of the mTOR signaling pathway
Cell Communication and Signaling·2024· 7 citedOpen Access
Small Spleen Peptides (SSPs) Shape Dendritic Cell Differentiation through Modulation of Extracellular ATP Synthesis Profile
Biomolecules·2024· 5 citedOpen Access
The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance
Antiviral Research·2024· 15 citedOpen Access
Variant-specific humoral immune response to SARS-CoV-2 escape mutants arising in clinically severe, prolonged infection
2024· 1 citedOpen Access
Smart containers in battery production
Procedia CIRP·2024Open Access
Antiviral Activity Against Hsv-1 of Triterpene Saponins from Anagallis Arvensis Is Related to the Fusion-Inhibitory Activity of Desglucoanagalloside B
SSRN Electronic Journal·2024· 1 citedOpen Access
page 1 of 26Next →

Frequent Co-authors

Christina Ehrhardt(19), Oliver Planz(16), Stephan Pleschka(15), Thorsten Wolff(14), Ulf R. Rapp(8), Matthias Goebeler(8), Johannes Roth(7), Mirco Schmolke(5), Dorothee Viemann(4), Walter J. Wurzer(4), Thomas Vogl(3), Clemens Sorg(3), Johannes G. Bode(3), Karin Kilian(3), Bernd Neufeld(3), Igor Mazur(3), Wolfgang Nacken(2), Dirk Foell(2), Volker Gerke(2), Thorsten Eierhoff(2)